EarlySense Granted United States Patent for Respiratory Trend Analysis Capability for Contact-Free, Patient Safety Monitoring

  EarlySense Granted United States Patent for Respiratory Trend Analysis
  Capability for Contact-Free, Patient Safety Monitoring System

Business Wire

WALTHAM, Mass. -- March 21, 2013

EarlySense, the market leader in Proactive Patient Care Solutions™, announced
today that the company has been granted a United States patent for the
respiratory trend analysis component of its contact-free, patient safety
monitoring system. The EarlySense solution is designed to help medical teams
in the medical surgical departments of hospitals to proactively respond to
early warning signs of deterioration and avoid adverse events and excessive
length of stay.

US Patent number 8,376,954 is titled Techniques for prediction and monitoring
of respiration-manifested clinical episodes. The technology provides a
contact-free method for predicting and monitoring a clinical episode. It does
so by sensing the breathing of a patient, then determining the breathing
pattern of the patient, and finally, analyzing any trends longer than one hour
and comparing them with a baseline. Inventors include three of four of the
company’s founders: Dr. Daniel Lange, Yossi Gross and Avner Halperin.

The results of a multi-site clinical trial, recently published, in an article
titled Early Recognition of Acutely Deteriorating Patients in Non- Intensive
Care Units: Assessment of an Innovative Monitoring Technology, by the Journal
of Hospital Medicine, found that changes in trends identified by the
EarlySense system were highly valuable in detecting the early warning signs of
patient deterioration. Please click here to view the abstract and for access
to the full set of results.

Dr. Jeffrey Rothschild, M.D., Clinical Device Director at Partners Healthcare,
Physician at Brigham and Women’s Hospital, Associate Professor of Medicine at
Harvard Medical School and co-author of the aforementioned paper said, “We
have known for a long time that beyond the absolute values of a patient’s
breathing and respiratory rate, effective analysis of trends enables earlier
detection of deterioration. This facilitates timely staff intervention which
can improve patient outcomes by averting or ameliorating adverse events. The
multi-center research results showed that the trends, detected by the
EarlySense system, enable effective identification of warning signs of
deterioration utilizing respiratory trends with a sensitivity of 100% and
specificity of 64%. Our paper supports the claim that continuous monitoring of
cardiac and respiratory trends on general care floors is effective in
facilitating early detection of deterioration in order to improve patient
outcomes.”

EarlySense CEO, Mr. Avner Halperin said, “EarlySense is proud to be the first
company to provide continuous, ‘contact-free’ trend analysis tools for the
general care floors. As there are no cumbersome leads or cuffs, patients enjoy
greater comfort and freedom of movement and, nurses are not burdened with
extra work and alarm fatigue. To date, EarlySense has logged more than five
million hours of patient monitoring hours and has received clinical reports
from three continents analyzing the findings. The reports cite hundreds of
cases where, based on information received from the EarlySense system,
clinicians saved patient lives as well as averted adverse events in the form
of patient deterioration brought on, for example, by respiratory depression.
The fact that EarlySense’s trend indications are now not only patent protected
but also clinically shown to provide valuable indications of deterioration
further supports the growing sentiment that this technology is on its way to
becoming the standard of care.”

Halperin continued, “Historically continuous patient monitoring was limited to
the more Acute Healthcare environments, such as an ICU. However, by designing
the EarlySense System with the less acute environments in mind, the company
has designed and introduced a system which produces fewer alarms, and
alleviates the challenges that may be produced by having patients attached to
leads and cuffs. Having a system, in the various environments within the
healthcare system, which is capable of detecting potentially harmful
situations early, notifying clinicians immediately, and offering quality
reporting in an effort to provide continuous feedback for improvement, is
essential in today’s healthcare environment. These deliverables help medical
teams to better manage a challenging workload created by shortages of
competent clinicians and increased patient loads, increase the quality of
patient care and save hospitals money, a distinct advantage as hospitals
continue to search for cost improvements due to shrinking margins.”

About EarlySense

EarlySense has brought to market an innovative technology designed to advance
proactive patient care and enable clinicians to achieve better patient
outcomes, by assisting in preventing adverse events from occurring through the
early identification of deterioration. The company’s flagship product, the
EarlySense System, is a continuous, contact-free, patient safety monitoring
solution that monitors and documents a patient’s vital signs and movement
using a sensor that is placed underneath a bed mattress. There are no leads or
cuffs to connect to the patient who has complete freedom of movement and is
not burdened by any cumbersome attachments. The system was initially designed
to monitor non-ICU ‘lower risk’ patients on medical surgical floors who are
usually monitored by nursing staff approximately once every four hours. The
system is currently installed at hospitals and rehabilitation centers in the
USA and Europe. It is also commercially available in Canada.Hospital
administrators report that patients, their families and staff feel more
comfortable knowing the system is in place. EarlySense Inc. is headquartered
in Waltham, MA. Investors include: JK&B, Pitango Venture Capital, Etgar
Challenge Fund, ProSeed VC Fund (TASE: PRSD), Docor International Management,
Noaber, and Bridge Investment Fund, and Peter Soderberg, managing partner of
Worthy Ventures Resources, LLC and former president and CEO of Hill-Rom
Holdings, Inc. (NYSE: HRC). For additional information, please visit
www.earlysense.com.

Follow us on Twitter.
Like us on Facebook.
See short overview video.

Contact:

EarlySense
Marjie Hadad, media liaison
617-939-9514
marjie.hadad@earlysense.com
 
Press spacebar to pause and continue. Press esc to stop.